Adaptimmune
Kobby Essien, PhD, currently serves as the Director of New Product Planning and Commercial Biomarkers/Diagnostics at Adaptimmune. Prior to this role, Kobby held the position of Associate Product Manager and Biopharmaceutical Leadership Development Analyst at Reata Pharmaceuticals. Kobby's academic experience includes a postdoctoral researcher role at the University of Pennsylvania School of Medicine.
This person is not in any teams
This person is not in any offices
Adaptimmune
2 followers
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment